01 | 19 | 06     St. Louis Post-Dispatch

Company raises $6 million for ovarian-cancer drug
Chlorogen Inc., which genetically engineers tobacco plants to produce therapeutic proteins, has raised $6 million to fund development of an innovative ovarian-cancer drug. | more |

09 | 16 | 05     St. Louis Post-Dispatch

Dow hires startup as partner in genetic innovation
Dow AgroSciences LLC has hired local startup Chlorogen Inc. to teach it a new way of creating genetically modified crops. | more |

08 | 27 | 05     St. Louis Post-Dispatch

Chlorogen prepares to grow with a little help
Chlorogen Inc. said Friday that, with a little help from the state, it will build a manufacturing plant in Cape Girardeau, Mo., and expand its laboratories at the Nidus Center for Scientific Enterprise in Creve Coeur. | more |

08 | 17 | 05     St. Louis Post-Dispatch

Chlorogen acquires exclusive rights to key technology
Chlorogen Inc., a Creve Coeur-based startup that is genetically engineering tobacco plants to produce proteins for medical use, said Tuesday that it has acquired exclusive rights to key technology. | more |

06 | 20 | 03     St. Louis Post-Dispatch

Creve Coeur startup develops human plasma from tobacco
Patented technique could reduce cost of producing protein-based drugs. In a twist on the "Little Shop of Horrors," with its blood-eating plant, a Creve Coeur startup is developing a way for tobacco plants to produce human plasma. | more |